(Q41145523)

English

Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).

scientific article published on February 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1 reference

Europe PubMed Central

Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

author name string

Kannel WB

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

language of work or name

0 references

publication date

1 February 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

6B-11B

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

An epidemiological perspective in hypertension problem solving

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Left ventricular hypertrophy and mortality--results from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Structural remodeling in hypertensive heart disease and the role of hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Potency of vascular risk factors as the basis for antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989232-6

7 January 2021

Identifiers

10.1016/S0002-9149(97)89232-6

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41145523&oldid=2269763059"